IXJ vs. PBPH
IXJ (iShares Global Healthcare ETF) and PBPH (Portfolio Building Block World Pharma and Biotech Index ETF) are both Health & Biotech Equities funds - IXJ tracks the S&P Global Healthcare Sector Index while PBPH tracks the BITA Global Pharma and Biotech Select Index. Both are passively managed. Their correlation of 0.93 suggests significant overlap in exposure. IXJ charges 0.46%/yr vs 0.13%/yr for PBPH.
Performance
IXJ vs. PBPH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IXJ achieves a -5.26% return, which is significantly lower than PBPH's -1.13% return.
IXJ
- 1D
- 0.39%
- 1M
- 0.34%
- YTD
- -5.26%
- 6M
- -4.88%
- 1Y
- 9.30%
- 3Y*
- 4.42%
- 5Y*
- 4.02%
- 10Y*
- 7.66%
PBPH
- 1D
- 0.58%
- 1M
- 0.07%
- YTD
- -1.13%
- 6M
- -0.02%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
IXJ vs. PBPH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
IXJ iShares Global Healthcare ETF | -5.26% | -1.20% |
PBPH Portfolio Building Block World Pharma and Biotech Index ETF | -1.13% | 0.76% |
Correlation
The correlation between IXJ and PBPH is 0.93, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Nov 26, 2025 | 0.93 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IXJ vs. PBPH — Risk / Return Rank
IXJ
PBPH
IXJ vs. PBPH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Global Healthcare ETF (IXJ) and Portfolio Building Block World Pharma and Biotech Index ETF (PBPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| IXJ | PBPH | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.64 | — | — |
Sortino ratioReturn per unit of downside risk | 1.06 | — | — |
Omega ratioGain probability vs. loss probability | 1.12 | — | — |
Calmar ratioReturn relative to maximum drawdown | 0.87 | — | — |
Martin ratioReturn relative to average drawdown | 2.11 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| IXJ | PBPH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.64 | — | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.28 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.49 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.42 | -0.04 | +0.46 |
Drawdowns
IXJ vs. PBPH - Drawdown Comparison
The maximum IXJ drawdown since its inception was -40.60%, which is greater than PBPH's maximum drawdown of -11.10%. Use the drawdown chart below to compare losses from any high point for IXJ and PBPH.
Loading charts...
Drawdown Indicators
| IXJ | PBPH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -40.60% | -11.10% | -29.50% |
Max Drawdown (1Y)Largest decline over 1 year | -10.78% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -18.14% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -18.14% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -27.35% | — | — |
Current DrawdownCurrent decline from peak | -9.27% | -8.69% | -0.58% |
Average DrawdownAverage peak-to-trough decline | -6.92% | -4.23% | -2.69% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.41% | — | — |
Volatility
IXJ vs. PBPH - Volatility Comparison
Loading charts...
Volatility by Period
| IXJ | PBPH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 3.75% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 10.05% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 14.55% | 16.78% | -2.23% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.21% | 16.78% | -2.57% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 15.67% | 16.78% | -1.11% |
IXJ vs. PBPH - Expense Ratio Comparison
IXJ has a 0.46% expense ratio, which is higher than PBPH's 0.13% expense ratio.
Dividends
IXJ vs. PBPH - Dividend Comparison
IXJ's dividend yield for the trailing twelve months is around 1.47%, more than PBPH's 0.09% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IXJ iShares Global Healthcare ETF | 1.47% | 1.40% | 1.50% | 1.38% | 1.17% | 1.12% | 1.27% | 1.42% | 2.11% | 1.46% | 1.73% | 2.85% |
PBPH Portfolio Building Block World Pharma and Biotech Index ETF | 0.09% | 0.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
With a correlation of 0.93, IXJ and PBPH move almost identically. Holding both adds very little diversification - you're essentially doubling your position in the same market segment. Choosing one is usually more capital-efficient.
On fees, PBPH is cheaper at 0.13% per year. The better choice depends on whether you care most about return, fees, risk, or income.
PBPH is cheaper with a 0.13% expense ratio, compared with 0.46% for IXJ.
IXJ has the higher dividend yield at 1.47%, compared with 0.09% for PBPH.
IXJ tracks S&P Global Healthcare Sector Index, while PBPH tracks BITA Global Pharma and Biotech Select Index. They also come from different issuers: iShares and Portfolio Building Block. Their fees differ too: 0.46% for IXJ and 0.13% for PBPH.
Find the right allocation for IXJ and PBPH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer